Recommended content

Canadian cannabis company Organigram achieves CA$5.3 million quarterly profit

Canadian cannabis producer Organigram Holdings swung to profitability during the first quarter of its 2023 fiscal year with net income of 5.3 million Canadian dollars ($4 million) despite a quarter-over-quarter decline in revenue.

Net revenue for the quarter ended Nov. 30, 2022, was CA$43.3 million, a decrease of 4.7% from the previous quarter and an increase of 43% compared to the same quarter last year, according to a news release.

ADVERTISEMENT

Organigram claimed a No. 3 position in the regulated Canadian adult-use marijuana market, with a leading market share in pre-milled cannabis flower and a third-place market share in gummies and hashish.

The company’s overall gross margin for the quarter was CA$23.9 million, improving from CA$14.2 million in the previous quarter.

CEO Beena Goldenberg said in a statement that Organigram achieved “the lowest cost of cultivation in the history of the company.”

“We maintained our market position

Read full article on Marijuana Business Daily

Follow us on Instagram or join us on facebook page

Be first to rate

Marijuana Business Daily
Source

More news